Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q2, 26 TTM Selling/general/admin expenses 61.74 M50.73 M62.39 M60.25 M54.15 M 238.52 M Research & development ————— — Operating income 28.53 M20.34 M19.21 M18.39 M34.32 M 100.45 M Non-Operating Income, Total -8.82 M-3.52 M-13.54 M-10.89 M-7.11 M -40.36 M Interest expense, net of interest capitalized 16.1 M7.38 M17.72 M17.52 M16 M 67.34 M Non-Operating Income, excl. Interest Expenses -25.58 M-4.65 M-31.7 M-29.11 M-20.81 M -107.2 M Unusual income/expense 662 K1.14 M445 K703 K-2.3 M -492 K Pretax income 19.71 M16.82 M5.67 M7.51 M27.21 M 60.1 M Equity in earnings 1.72 M381 K1.02 M1.18 M548 K 4.46 M Taxes 6.58 M6.61 M4.59 M944 K8.76 M 20.87 M Non-controlling/minority interest -1.3 M793 K704 K563 K-1.29 M -1.32 M After tax other income/expense ————— — Net income before discontinued operations 14.44 M9.42 M373 K6 M19.74 M 40.55 M Discontinued operations ————— — Net income 14.44 M9.42 M373 K6 M19.74 M 40.55 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 14.44 M9.42 M373 K6 M19.74 M 40.55 M Basic earnings per share (Basic EPS) 0.30.190.010.120.4 0.83 Diluted earnings per share (Diluted EPS) 0.290.190.010.120.4 0.82 Average basic shares outstanding 48.85 M49.19 M49.22 M49.08 M49.12 M — Diluted shares outstanding 49.05 M49.47 M49.47 M49.37 M49.78 M — EBITDA 44.01 M27.24 M34.81 M34.79 M49.87 M 163.48 M EBIT 28.53 M20.34 M19.21 M18.39 M34.32 M 100.45 M Cost of revenue 874.84 M583.74 M874.45 M871.88 M884.05 M 3.51 B Other cost of goods sold 859.36 M576.84 M858.86 M855.48 M868.5 M 3.44 B Depreciation & amortization (cash flow) 15.48 M6.9 M15.6 M16.4 M15.55 M 63.02 M